MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Waters Corp

Fermé

SecteurSoins de santé

287.21 -3.35

Résumé

Variation du prix de l'action

24h

Actuel

Min

284.48

Max

297.07

Chiffres clés

By Trading Economics

Revenu

-110M

121M

Ventes

-211M

662M

P/E

Moyenne du Secteur

27.628

39.857

BPA

2.25

Marge bénéficiaire

18.344

Employés

7,600

EBITDA

-193M

152M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+33.71% upside

Dividendes

By Dow Jones

Prochains Résultats

4 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-4.2B

18B

Ouverture précédente

290.56

Clôture précédente

287.21

Sentiment de l'Actualité

By Acuity

65%

35%

325 / 376 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Waters Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 juil. 2025, 14:26 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14 juil. 2025, 11:08 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15 juil. 2025, 18:32 UTC

Acquisitions, Fusions, Rachats

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 juil. 2025, 18:31 UTC

Acquisitions, Fusions, Rachats

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14 juil. 2025, 16:53 UTC

Actions en Tendance

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 juil. 2025, 16:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 juil. 2025, 15:06 UTC

Acquisitions, Fusions, Rachats

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14 juil. 2025, 14:11 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14 juil. 2025, 10:53 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14 juil. 2025, 10:22 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14 juil. 2025, 10:21 UTC

Acquisitions, Fusions, Rachats

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14 juil. 2025, 10:20 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14 juil. 2025, 10:19 UTC

Acquisitions, Fusions, Rachats

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14 juil. 2025, 10:19 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14 juil. 2025, 10:18 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14 juil. 2025, 10:18 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14 juil. 2025, 10:17 UTC

Acquisitions, Fusions, Rachats

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14 juil. 2025, 10:16 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14 juil. 2025, 10:16 UTC

Acquisitions, Fusions, Rachats

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14 juil. 2025, 10:15 UTC

Acquisitions, Fusions, Rachats

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14 juil. 2025, 10:15 UTC

Acquisitions, Fusions, Rachats

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Comparaison

Variation de prix

Waters Corp prévision

Objectif de Prix

By TipRanks

33.71% hausse

Prévisions sur 12 Mois

Moyen 397 USD  33.71%

Haut 500 USD

Bas 330 USD

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

13 ratings

6

Achat

7

Maintien

0

Vente

Score Technique

By Trading Central

345.22 / 351.01Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

325 / 376Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.